Evidence map›Paper›PMID 41049757›Full record

ArticleActa pharmaceutica Sinica. B2025

Ling Xu, Zimu Zhang, Juanjuan Yu, Tongting Ji, Jia Cheng, Xiaodong Fei, Xinran Chu, Yanfang Tao, Yan Xu, Pengju Yang and 25 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Dysregulation of the PATZ1/CTCF Balance Silences ZBTB20 to Drive Melanoma Progression.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Ling XuChildren's Hospital of Soochow University, Suzhou 215003, China.
Zimu ZhangInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.
Juanjuan YuChildren's Hospital of Soochow University, Suzhou 215003, China.
Tongting JiChildren's Hospital of Soochow University, Suzhou 215003, China.
Jia ChengChildren's Hospital of Soochow University, Suzhou 215003, China.
Xiaodong FeiDepartment of Radiology, Children's Hospital of Soochow University, Suzhou 215003, China.
Xinran ChuDepartment of Hematology, Children's Hospital of Soochow University, Suzhou 215003, China.
Yanfang TaoDepartment of Traditional Chinese Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.
Yan XuDepartment of Pediatrics, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000 China.
Pengju YangChildren's Hospital of Soochow University, Suzhou 215003, China.
Wenyuan LiuDepartment of Pediatrics, the Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Gen LiInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.
Yongping ZhangDepartment of Hematology, Children's Hospital of Soochow University, Suzhou 215003, China.
Yan LiDepartment of Pediatrics, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000 China.
Fenli ZhangClinical Medicine, Guizhou Medical University, Guiyang 550000, China.
Ying YangClinical Medicine, Guizhou Medical University, Guiyang 550000, China.
Bi ZhouChildren's Hospital of Soochow University, Suzhou 215003, China.
Yumeng WuChildren's Hospital of Soochow University, Suzhou 215003, China.
Zhongling WeiDepartment of Hematology, Children's Hospital of Soochow University, Suzhou 215003, China.
Yanling ChenChildren's Hospital of Soochow University, Suzhou 215003, China.
Jianwei WangInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.
Di WuInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.
Xiaolu LiInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.
Yang YangInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.
Guanghui QianInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.
Hongli YinInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.
Shuiyan WuDepartment of Hematology, Children's Hospital of Soochow University, Suzhou 215003, China.
Shuqi ZhangDepartment of Pediatrics, the First Affiliated Hospital of Wannan Medical College, Wuhu 241002, China.
Dan LiuDepartment of Blood Transfusion, Children's Hospital of Soochow University, Suzhou 215003, China.
Jun-Jie FanDepartment of Hematology, Children's Hospital of Soochow University, Suzhou 215003, China.
Lei ShiDepartment of Medicinal Chemistry, Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
Xiaodong WangDepartment of Orthopaedics, Children's Hospital of Soochow University, Suzhou 215003, China.
Shaoyan HuDepartment of Hematology, Children's Hospital of Soochow University, Suzhou 215003, China.
Jun LuDepartment of Hematology, Children's Hospital of Soochow University, Suzhou 215003, China.
Jian PanInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive hematologic malignancy with a poor prognosis, despite advancements in treatment. Many patients struggle with relapse or refractory disease. Investigating the role of the super-enhancer (SE) regulated gene ubiquitin-specific protease 20 (

Indexed as

GSK2643943AH3K27ac ChIP-seqHIF1APotential targetSuper enhancerT-ALLTranscription regulationUSP20

Identifiers

PMID41049757
PMCPMC12491697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.